化合物WHI-P180 T2032
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
100 mg | 211555-08-7 | ¥3,520.00 | 询底价 |
2 mg | 211555-08-7 | ¥347.00 | 询底价 |
10 mg | 211555-08-7 | ¥953.00 | 询底价 |
1 mL | 211555-08-7 | ¥625.00 | 询底价 |
25 mg | 211555-08-7 | ¥1,580.00 | 询底价 |
5 mg | 211555-08-7 | ¥619.00 | 询底价 |
1 mg | 211555-08-7 | ¥245.00 | 询底价 |
50 mg | 211555-08-7 | ¥2,380.00 | 询底价 |
Product Introduction
Bioactivity
英文名: WHI-P180
描述: WHI-P180 (Janex 3) 是 EGFR 和 Cdk2 抑制剂,IC50 分别为 4.0 和 1.0 μM。
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 45 mg/mL (151.36 mM)
关键字: HER1 | Janex3 | WHI P180 | RET | WHI-P 180 | EGFR | WHI-P-180 | Vascular endothelial growth factor receptor | Inhibitor | Janex-3 | WHI-P180 | WHIP180 | inhibit | VEGFR | ErbB-1 | Epidermal growth factor receptor
相关产品: 4-Hydroxycinnamamide | AG-494 | Icotinib | EGFR-IN-16 | Afatinib Dimaleate | Chrysophanol | AEE788 | Os30 | EGFR-IN-2 | Mobocertinib
相关库: Anti-Cancer Compound Library | Membrane Protein-targeted Compound Library | Anti-Lung Cancer Compound Library | Kinase Inhibitor Library | Inhibitor Library | Anti-Colorectal Cancer Compound Library | Anti-Cancer Active Compound Library | Tyrosine Kinase Inhibitor Library | Apoptosis Compound Library | NO PAINS Compound Library
化合物WHI-P180 T2032信息由TargetMol中国为您提供,如您想了解更多关于化合物WHI-P180 T2032报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途